Advances in Bioscience and Biotechnology

Volume 4, Issue 5 (May 2013)

ISSN Print: 2156-8456   ISSN Online: 2156-8502

Google-based Impact Factor: 1.18  Citations  h5-index & Ranking

High-level secretory expression, purification, and characterization of an anti-human Her II monoclonal antibody, trastuzumab, in the methylotrophic yeast Pichia pastoris

HTML  XML Download Download as PDF (Size: 774KB)  PP. 640-646  
DOI: 10.4236/abb.2013.45084    5,942 Downloads   9,797 Views  Citations

ABSTRACT

DNA fragments encoding the light chain and heavy chain genes of an anti-human HER II antibody, trastuzumab, fused with an egg-lysozyme signal peptide were synthesized based on the codon bias of the methylotrophic yeast Pichia pastoris. These fragments were inserted into a site between the AOX 1-promoter and -terminator in pPICZ A to be expressed by P. pastoris. The expression vector was linearized, and introduced into P. pastoris GS115 by electroporation. After the checking of several transformants with PCR to ensure a precise insertion, one was selected and cultured to examine antibody production. The level of production reached 10 mg/L in a flask with medium containing 1% methanol. The heavy chain and light chain of the product were assembled to form a hetero tetramer, as detected by dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). N-terminal amino acid sequencing revealed that the signal peptides of both chains were well processed. The mobility of the product in SDS-PAGE after treatment with Peptide N-Glycosidase F indicated the heavy chain to be N-glycosylated. Further analysis of the N-glycans with a mass spectrometer revealed a mixture of Man9-GlcNAc2, Man10-GlcNAc2, Man11-GlcNAc2 and Man12-GlcNAc2, but no hyper-mannosylated glycans. ELISA, surface plasmon resonance, and flow cytometric studies showed the affinity curve and Kd value for the antigen, HER II, and reactivity to a HER2-overexpressing breast cancer cell-line, SK-BR-3, to be almost the same as for the clinically used trastuzumab produced by CHO.

Share and Cite:

Shibui, T. , Bando, K. and Misawa, S. (2013) High-level secretory expression, purification, and characterization of an anti-human Her II monoclonal antibody, trastuzumab, in the methylotrophic yeast Pichia pastoris. Advances in Bioscience and Biotechnology, 4, 640-646. doi: 10.4236/abb.2013.45084.

Cited by

[1] Aspects of “antigen–antibody” interaction of chicken infectious bronchitis virus determined by surface plasmon resonance
… Acta Part A: Molecular …, 2022
[2] Trastuzumab in Breast Cancer Treatment: The Era of Biosimilars
Anti-Cancer Agents in …, 2022
[3] Diagnostics of cattle leucosis by using a biosensor based on surface plasmon resonance phenomenon.
2019
[4] Inducible promoters and functional genomic approaches for the genetic engineering of filamentous fungi
Applied Microbiology and Biotechnology, 2018
[5] Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2013–2014
2018
[6] Exploring the potential of Saccharomyces cerevisiae for biopharmaceutical protein production
Current Opinion in Biotechnology, 2017
[7] РОЗРОБКА КОНСТРУКТОРСЬКО-ТЕХНОЛОГІЧНИХ МЕТОДІВ ПІДВИЩЕННЯ ТОЧНОСТІ ВИМІРЮВАННЯ ТА ЧУТЛИВОСТІ ПРИЛАДІВ НА ОСНОВІ …
2016
[8] РОЗРОБКА КОНСТРУКТОРСЬКО-ТЕХНОЛОГІЧНИХ МЕТОДІВ ПІДВИЩЕННЯ ТОЧНОСТІ ВИМІРЮВАННЯ ТА ЧУТЛИВОСТІ ПРИЛАДІВ НА ОСНОВІ …
2016
[9] High Levels Production of Recombinant Human Activin A—Effect upon in Vivo Follicle Stimulation
Advances in Bioscience and Biotechnology, 2015
[10] Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2009–2010
Mass Spectrometry Reviews, 2015
[11] Expression of antimicrobial peptide dybowskin-2CDYa and hEGF in pichia pastoris and characterization of its dual function
2014
[12] Biopharmaceutical protein production by Saccharomyces cerevisiae: current state and future prospects
Pharmaceutical Bioprocessing, 2014
[13] Biopharmaceutical protein production bySaccharomyces cerevisiae: current state and future prospects
2014

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.